Honda Mitsuo, Wang Rui, Kong Wing-Pui, Kanekiyo Masaru, Akahata Wataru, Xu Ling, Matsuo Kazuhiro, Natarajan Kannan, Robinson Howard, Asher Tedi E, Price David A, Douek Daniel C, Margulies David H, Nabel Gary J
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
J Immunol. 2009 Aug 15;183(4):2425-34. doi: 10.4049/jimmunol.0900581. Epub 2009 Jul 20.
Prime-boost immunization with gene-based vectors has been developed to generate more effective vaccines for AIDS, malaria, and tuberculosis. Although these vectors elicit potent T cell responses, the mechanisms by which they stimulate immunity are not well understood. In this study, we show that immunization by a single gene product, HIV-1 envelope, with alternative vector combinations elicits CD8(+) cells with different fine specificities and kinetics of mobilization. Vaccine-induced CD8(+) T cells recognized overlapping third V region loop peptides. Unexpectedly, two anchor variants bound H-2D(d) better than the native sequences, and clones with distinct specificities were elicited by alternative vectors. X-ray crystallography revealed major differences in solvent exposure of MHC-bound peptide epitopes, suggesting that processed HIV-1 envelope gave rise to MHC-I/peptide conformations recognized by distinct CD8(+) T cell populations. These findings suggest that different gene-based vectors generate peptides with alternative conformations within MHC-I that elicit distinct T cell responses after vaccination.
基于基因载体的初免-加强免疫接种方案已被开发出来,用于生产针对艾滋病、疟疾和结核病更有效的疫苗。尽管这些载体能引发强烈的T细胞反应,但其刺激免疫的机制尚未完全明确。在本研究中,我们发现用单一基因产物HIV-1包膜蛋白与不同载体组合进行免疫接种,可引发具有不同精细特异性和动员动力学的CD8(+)细胞。疫苗诱导的CD8(+) T细胞识别重叠的第三个V区环肽。出乎意料的是,两种锚定变体与H-2D(d)的结合比天然序列更好,并且不同载体引发了具有不同特异性的克隆。X射线晶体学揭示了MHC结合肽表位在溶剂暴露方面的主要差异,这表明加工后的HIV-1包膜蛋白产生了可被不同CD8(+) T细胞群体识别的MHC-I/肽构象。这些发现表明,不同的基于基因的载体在MHC-I内产生具有不同构象的肽,这些肽在接种疫苗后引发不同的T细胞反应。